W. Richard Staub
Fortune : 3 M $ au 31/05/2026
Fortune : 3 M $ au 31/05/2026
Actuellement, W. Richard Staub est président des solutions de recherche et de développement chez IQVIA Holdings, Inc. Il est également membre du conseil d'administration de TLC Operations, Inc. Dans sa carrière antérieure, M. Staub a occupé le poste de directeur du marketing chez Zeneca Pharmaceuticals, de président, de directeur général et de directeur chez Novella Clinical, Inc. et de premier vice-président chargé du développement commercial mondial chez Pharmaceutical Product Development LLC. W. Richard Staub a obtenu un diplôme de premier cycle à l'Université de Caroline du Nord à Charlotte.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IQVIA HOLDINGS INC 0,01 % | 09/02/2026 | 18 812 ( 0,01 % ) | 3 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| IQVIA HOLDINGS INC. | Directeur Technique/Scientifique/R&D | 25/09/2023 |
TLC Operations, Inc.
TLC Operations, Inc. Personnel ServicesCommercial Services Provides cognitive disability and dev disability services | Directeur/Membre du Conseil | - |
Pappas Capital LLC
Pappas Capital LLC Investment ManagersFinance Pappas Ventures invests in companies located in the across the globe and primarily in United States, Canada and Asia. The firm focuses on next-generation life science, agriculture, and technology. It participates in seed and early-stage transactions. | Private Equity Investor | 01/10/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
Novella Clinical, Inc.
Novella Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical research development solutions | Directeur Général | 01/01/2013 |
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Operates as a contract research organization for life-changing therapies | Corporate Officer/Principal | 01/01/2004 |
Zeneca Pharmaceuticals
Zeneca Pharmaceuticals Pharmaceuticals: MajorHealth Technology Manufactures medicines | Sales & Marketing | 01/01/1997 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 7 |
|---|---|
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Operates as a contract research organization for life-changing therapies | Commercial Services |
Pappas Capital LLC
Pappas Capital LLC Investment ManagersFinance Pappas Ventures invests in companies located in the across the globe and primarily in United States, Canada and Asia. The firm focuses on next-generation life science, agriculture, and technology. It participates in seed and early-stage transactions. | Finance |
The University of North Carolina at Chapel Hill
The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TLC Operations, Inc.
TLC Operations, Inc. Personnel ServicesCommercial Services Provides cognitive disability and dev disability services | Commercial Services |
Novella Clinical, Inc.
Novella Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical research development solutions | Commercial Services |
Zeneca Pharmaceuticals
Zeneca Pharmaceuticals Pharmaceuticals: MajorHealth Technology Manufactures medicines | Health Technology |
IQVIA Holdings, Inc.
IQVIA Holdings, Inc. BiotechnologyHealth Technology Provides outsourced clinical research and trial, mission critical information, technology, healthcare and patient engagement services | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national